Transgenic plants exhibiting resistance to a spectrum of pathogens
AssigneeUniversity of Victoria Innovation and Development Corporation
InventorsSantosh Misra, William W. Kay, Milan Osusky
Life of this patent
Estimating the term…
Abstract
Transgenic plants that express antimicrobial CEMA and/or CEMA-related peptides are disclosed. In certain embodiments, these plants have enhanced, broad-spectrum pathogen resistance and are useful as agricultural or horticultural crops. In other embodiments, the plants are used to produce large quantities of the CEMA and/or CEMA-related peptides.
Claims77
A transgenic plant, wherein the plant expresses a cationic peptide selected from the group consisting of CEMA and CEMA-related peptides.
A transgenic plant, comprising a recombinant nucleic acid molecule, wherein the nucleic acid molecule encodes a fusion peptide having a formula P-C or P-E, wherein C is a CEMA peptide, E is a CEMA-related peptide, and P is an anionic pro-region peptide.
A transgenic plant, comprising a recombinant nucleic acid molecule encoding a fusion peptide having a formula selected from the group consisting of P-S-C and P-S-E, wherein C is a CEMA peptide, E is a CEMA-related peptide, P is an anionic pro-region peptide, and S is a spacer peptide.
A transgenic plant, comprising a nucleic acid molecule encoding a peptide comprising an amino acid sequence selected from the group consisting of:
- (a) SEQ ID NO:
- 2 and SEQ ID NO:
- 4;
- (b) amino acid sequences that differ from an amino acid sequence specified in (a) by one or more conservative amino acid substitutions;
- and
- (c) amino acid sequences that share at least 40% sequence identity with an amino acid sequence specified in (a), wherein the peptide has CEMA biological activity.
A transgenic plant, comprising a recombinant nucleic acid molecule encoding a peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 2 and SEQ ID NO:
- 4.
A method for producing a transgenic plant that expresses a terminally extended cationic peptide conferring broad-spectrum pathogen resistance and that is compatible with plant physiology, the method comprising:
- (a) transforming a plant cell with a nucleic acid sequence that encodes an N-terminally extended cationic peptide;
- (b) expressing the terminally extended cationic peptide in a plant;
- and
- (c) determining that the plant expressing the terminally extended peptide is resistant to a broad-spectrum of pathogens.
Dependencies are inferred from the claim text.